Cleared Traditional

K062840 - TRIAGE PROTEIN C CONTROLS AND CALIBRATION VERIFICATION CONTROLS

K062840 is an FDA 510(k) clearance for TRIAGE PROTEIN C CONTROLS AND CALIBRATI..., manufactured by Biosite Incorporated. The device is a Class 2 Hematology device with product code GGN cleared through the Traditional 510(k) pathway after a 160-day FDA review.

K062840 · Biosite Incorporated · Hematology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 2007
Decision
160d
Days
Class 2
Risk

K062840 is an FDA 510(k) clearance for the TRIAGE PROTEIN C CONTROLS AND CALIBRATION VERIFICATION CONTROLS. Classified as Plasma, Coagulation Control (product code GGN), Class II - Special Controls.

Submitted by Biosite Incorporated (San Diego, US). The FDA issued a Cleared decision on March 1, 2007 after a review of 160 days - an extended review cycle.

This device falls under the Hematology FDA review panel, regulated under 21 CFR 864.5425 - the FDA hematology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Hematology review framework, consistent with the majority of Class II 510(k) submissions.

View all Biosite Incorporated devices

FDA 510(k) Submission Details - K062840

510(k) Number K062840 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 22, 2006
Decision Date March 01, 2007
Days to Decision 160 days
Submission Type Traditional
Review Panel Hematology (HE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
47d slower than avg
Panel avg: 113d · This submission: 160d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GGN Device Classification - Class 2, Special Controls

Product Code GGN Plasma, Coagulation Control
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 864.5425
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Hematology devices follow this clearance model.

Regulatory Peers - GGN Plasma, Coagulation Control

All 91
Devices cleared under the same product code (GGN) and FDA review panel - the closest regulatory comparables to K062840.
HEPARIN ASSAY CONTROLS
K103313 · Medtronic, Inc. · Dec 2010
HEMOSIL INR VALIDATE, HEMOSIL ISI CALIBRATE, ISIWEB (SOFTWARE)
K090563 · Instrumentation Laboratory CO · Oct 2009
HEMOSIL ROUTINE CONTROL LEVEL 1, LEVEL 2, LEVEL 3 UNASSAYED
K082859 · Instrumentation Laboratory CO · Dec 2008
COAGUCHEK XS PT CONTROLS
K063823 · Roche Diagnostics Corp. · Jan 2007
BIOPHEN LMWH CONTROL, LMWH CONTROL LOW, UFH CONTROL, HEPARIN CALIBRATOR & UFH CALIBRATOR
K051472 · Hyphen Biomed · Dec 2005
TRIAGE(R) D-DIMER CALIBRATION VERIFICATION CONTROLS
K050799 · Biosite Incorporated · Jun 2005